Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer
CNR Ibb | back to homepage
CNR Ibb | back to homepage
▲NavBar
Advanced search Ricerca avanzata▼

Content Contiene: [X]
Options Opzioni:      Extended Estesa    
Authors Autori: [X] 
Paper type Tipo di lavoro: [X]  
Start date Data iniziale: End date Data finale: [X]     
Site Sede:
IBB affiliation Affiliazione IBB     
    
[Clear form Pulisci modulo]



Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer (179 views visite)

Nguyen XC, Nguyen VK, Tran MT, Maurea S, Salvatore M

World Journal Of Nuclear Medicine (ISSN: 1450-1147), 2014 May; 13(2): 112-119.

Export to Esporta in BibTeX    Export to Esporta in EndNote

Paper type Tipo di articolo: Journal Article,

Impact factor: 5.563, 5-year impact factor Impact factor a 5 anni: 6.119

Url: Not available. Non disponibile.

Keywords Parole chiave: 2-Deoxy-2-[18f]-Fluoro-D-Glucose, Nonsmall Cell Lung Cancer, Sum Of Maximum Standardized Uptake Value, Tumor Burden, 2-Deoxy-2- [18f] -Fluoro-D-Glucose,

Affiliations Affiliazioni:
*** IBB - CNR ***

Unit of PET/CT and Cyclotron, Choray Hospital, Ho Chi Minh City, Vietnam.


References Riferimenti:
Not available. Non disponibili.
Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer

To assess the prognostic value of maximum standardized uptake value (maxSUV) of the primary tumor (maxSUVpt), maxSUV of whole-body tumors (maxSUVwb) and sum of maximum standardized uptake value (sumaxSUV) measured by the sum of maxSUVs of the primary tumor, metastatic lymph nodes, and metastatic lesions per each organ on fluoro-D-glucose-positron emission tomography/computed tomography in advanced non-small cell lung cancer (NSCLC). Eighty-three patients (49 male, 34 female) with advanced NSCLC were enrolled. Seventeen patients had Stage IIIA, 21 Stage IIIB, and 45 Stage IV. maxSUVpt, maxSUVwb, sumaxSUV, age, gender, tumor-cell type, T stage, N stage, overall stage, primary tumor size, and specific treatment were analyzed for correlation with overall survival. Median follow-up duration was 13 months. Fifty patients were dead during a median follow-up time of 11 months and 33 patients were alive with a median time of 15 months. Univariate analysis revealed that overall survival was significantly correlated with sumaxSUV (≥35 vs.
Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer

▼    Clinical Oncology
Prognostic Value of Fluoro-D-glucose Uptake of Primary Tumor and Metastatic Lesions in Advanced Nonsmall Cell Lung Cancer


Vai a fine pagina   Versione per copia e incolla facile   Esporta tutto in BibTeX   Esporta tutto in EndNote


Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (328 visite) (PDF 6 visite)
Eur J Radiol (ISSN: 0720-048x), 2017 Aug; 93: 107-113.
Impact Factor: 2.843
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (321 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2016 Dec 28; 8(6): 10007-10024.
Impact Factor: 5.168
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mainenti PP, Pizzuti LM, Segreto S, Comerci M, Fronzo SD, Romano F, Crisci V, Smaldone M, Laccetti E, Storto G, Alfano B, Maurea S, Salvatore M, Pace L
* Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification (861 visite) (PDF 232 visite)
Eur J Radiol (ISSN: 0720-048x, 0720-048xlinking), 2016 Jan; 85(1): 113-124.
Impact Factor: 2.462
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (416 visite)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

Natella V, Merolla F, Giampaolino P, Bifulco G, Mainenti PP, Insabato L
* A huge malignant perivascular epithelioid cell tumor (PEComa) of the uterine cervix and vagina (353 visite)
Pathol Res Pract (ISSN: 0344-0338), 2014 Mar; 210(3): 186-188.
Impact Factor: 1.397
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (333 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli    Esporta in BibTeX    Esporta in EndNote

Costa B, Bendinelli S, Gabelloni P, Da Pozzo E,  Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C
* Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor (314 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013; 8(8): e72281-e72281.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Larobina M, Del Vecchio S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L
* Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma (455 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

8 Records (7 escludendo Abstract e Conferenze).
Impact factor totale: 26.771 (20.997 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 27.4 (20.998 escludendo Abstract e Conferenze).





Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:51
179 views visite. Last view on Ultima visita in data Tuesday 11 May 2021, 12:09:50